Listeners Club

Forgot Password

Not a Member? Sign up here!

banner

Local Headlines

Findings released for study of convalescent plasma treatment of early COVID-19

Nuvance Health participated in a nationwide, 16-month study that showed convalescent plasma can be effective and safe in treating early COVID-19.  The clinical trial, led by Johns Hopkins, involved more than 1,100 patients throughout the country between June 2020 and October 2021.  Patients were either given the plasma or placebo with success measured by the patient not requiring hospitalization within 28 days of the transfusion.  Assistant vice president of Clinical Trials MarieElena Cordisco noted that the study started before vaccinations became available and that the results showed giving convalescent plasma within the first nine days of testing prevented hospitalization for COVID 19.  Nuvance Health offered the study at Danbury and Norwalk Hospitals along with Vassar Brothers Medical Center. The New England Journal of Medicine recently published the findings.

On Air Now

Dave Rinelli

Local Headlines